Redefining massive transfusion by König, Thomas C et al.
BioMed  Central
Page 1 of 2
(page number not for citation purposes)
Scandinavian Journal of Trauma, 
Resuscitation and Emergency Medicine
Open Access Oral presentation
Redefining massive transfusion
Thomas C König*, Timothy Morris, Christine Gaarder, Marc Maegele, 
Carel Goslings, Shuba Allard, Mitchell Cohen, Jean Francois Pittet, 
Pär Johansson, Simon Stanworth and Karim Brohi
Address: Royal London Hospital Trauma Clinical Academic Unit, Royal London Hospital, Whitechapel, London E1 1BB, UK
Email: Thomas C König* - tom.konig@bartsandthelondon.nhs.uk
* Corresponding author    
Background
The concept of massive transfusion was developed to trig-
ger clotting factor therapy for the treatment of coagulopa-
thy due to dilution, after a certain number of units of
packed red blood cells. It has been defined as the replace-
ment of circulating volume or the transfusion of more
than 6 or 10 units of packed red blood cells (PRBC) in the
24 hours after injury. Until recently there has been little
consideration of the transfusion of clotting products.
Given the recent identification of the early coagulopathy
of trauma and the new therapeutic regimens for massive
transfusion, there is therefore a need to re-examine the
concept of massive transfusion.
Aims
To determine if there is a clinically relevant definition of
massive transfusion based on outcome.
Methods
A retrospective multi centre registry analysis of the trans-
fusion practices of five centres in Europe and North Amer-
ica was carried out. 5150 patients were studied. Data was
collected on demographics, mechanism of injury, 24 hour
PRBC requirement and mortality.
Results
There was a linear increase in the number of PRBC trans-
fused and mortality (Figure 1). No clear threshold above
which mortality increased was found. Each additional
unit of blood transfused added cumulatively less to the
mortality risk (Figure 2).
Conclusion
The current definitions of massive transfusion are arbi-
trary and do not select patients on the basis of outcome.
The differences in transfusion practices amongst centres
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around the world and the change in the treatment of the
coagulopathy of trauma with PRBC and use of blood
products in higher ratios may mean that massive transfu-
sion has become an outdated concept.
Figure 2